CRDF

Cardiff Oncology INC

-$37.5M

Net Activity

Institutions Holding

115

Popularity Rank

#4162

Avg Weight

0.02%

Total Value

$40.6M

Ownership Trend

115 institutions currently hold CRDF, with 47 net buyers and 53 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

53

Net Buying Institutions

47

Key Holders

View all 115 holding institutions

Quarterly Activity

Recent Activity

+$6.7M

Total Buy Value

$40.3M

Total Sell Value

New buy18
Trim39
Add29
Sold out14

47

Net Buyers

53

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-07-16
2026-07-16

Cardiff Oncology entered into a securities purchase agreement on July 14 to sell common stock and warrants to institutional investors and insiders. The offering raised about $10.05 million in gross proceeds, with institutions buying 8.57 million shares at $1.05 each and insiders buying 721,649 shares at $1.455 each. The deal closed on July 16, and the company plans to use the proceeds for working capital and general corporate purposes.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding CARDIFF ONCOLOGY INC (CRDF)?
Major stakeholders currently include BlackRock, Inc. ($6.4M), Vanguard Capital Management LLC ($4.6M), Laurion Capital Management LP ($4.3M). Based on the latest 13F filings, there are a total of 115 tracked investment funds and institutions maintaining positions in CRDF.
What is the overall institutional sentiment toward CRDF recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $37.5M, driven by 47 managers accumulating shares while 53 reduced their exposure.
Which institutions have been selling or reducing their CRDF positions?
In the latest period, 39 funds trimmed their holdings, and 14 managers completely exited their positions. The aggregate reported sell value was $40.3M.
Are there any notable investors adding CRDF to their portfolios?
Yes, buying activity remains notable. 18 institutions opened new positions in {ticker}, and 29 existing holders added to their shares. The total reported buy value for the quarter amounted to $6.7M.

Related Stocks